Basic Study
Copyright ©The Author(s) 2019.
World J Gastrointest Oncol. Jun 15, 2019; 11(6): 470-488
Published online Jun 15, 2019. doi: 10.4251/wjgo.v11.i6.470
Figure 1
Figure 1 Enzyme-Linked Immuno-Sorbent Assays determined preoperative and postoperative angiopoietin 2 levels of plasma and wound fluid levels in colorectal surgery benign patients and malignant patients. A: Colorectal surgery benign patients. Preoperative vs Postoperative plasma: Preoperative vs Postoperative day 1 (n = 26), bP < 0.01; Preoperative vs Postoperative day 3 (n = 23), bP < 0.01; Preoperative vs Postoperative day 7-13 (n = 16), bP < 0.01; Preoperative vs Postoperative day 14-20 (n = 6), aP < 0.05. Plasma vs wound fluid: Postoperative day 1 (plasma, n = 26) vs Postoperative day 1 (wound fluid, n = 30), bP < 0.01; Postoperative day 3 (plasma, n = 23) vs Postoperative day 3 (wound fluid, n = 28), bP < 0.01; Postoperative day 7-13 (plasma, n = 16) vs Postoperative day 7-13 (wound fluid, n = 14), bP < 0.01; Postoperative day 14-20 (plasma, n = 6) vs Postoperative day 14-20 (wound fluid, n = 4); bP < 0.01. Plasma and wound fluid protein levels are expressed as median and 75% quartile range (Statistical significance is expressed as aP < 0.05, bP < 0.01); B: Colorectal surgery malignant patients. Preoperative vs Postoperative plasma: Preoperative vs Postoperative day 1 (n = 35), dP < 0.01; Preoperative vs Postoperative day 3 (n = 28), dP < 0.01; Preoperative vs Postoperative day 7-13 (n = 17), dP < 0.01; postoperative vs Postoperative day 14-20 (n = 7), cP < 0.05. Plasma vs wound fluid; Postoperative day 1 (plasma, n = 35) vs Postoperative day 1 (wound fluid, n = 33), dP < 0.01; Postoperative day 3 (plasma, n = 28) vs Postoperative day 3 (wound fluid, n = 29), dP < 0.01; Postoperative day 7-13 (plasma, n = 17) vs Postoperative day 7-13 (wound fluid, n = 20), dP < 0.01; Postoperative day 14-20 (plasma, n = 7) vs Postoperative day 14-20 (wound fluid, n = 8), dP < 0.01. Plasma and wound fluid protein levels are expressed as median and 75% quartile range. Statistical significance is expressed as cP < 0.05, dP < 0.01. Preop: Preoperative; POD: Postoperative day; PLS: Plasma; WFL: Wound fluid.
Figure 2
Figure 2 Enzyme-Linked Immuno-Sorbent Assays determined preoperative and postoperative vascular endothelial growth factor levels of plasma and wound fluid levels in colorectal surgery benign patients and malignant patients. A: Colorectal surgery benign patients. Preoperative vs Postoperative plasma: Preoperative vs. Postoperative day 1 (n = 26), fP < 0.01; Preoperative vs Postoperative day 3 (n = 23), fP < 0.01 Preoperative vs Postoperative day 7-13 (n = 16), fP < 0.01; Preoperative vs Postoperative day 14-20 (n = 6), ns. Plasma vs wound fluid: Postoperative day 1 (plasma, n = 26) vs Postoperative day 1 (wound fluid, n = 30), fP < 0.01; Postoperative day 3 (plasma, n = 23) vs Postoperative day 3 (wound fluid, n = 28) , fP < 0.01; Postoperative day 7-13 (plasma, n = 16) vs Postoperative day 7-13 (wound fluid, n = 14), fP < 0.01; Postoperative day 14-20 (plasma, n = 6) vs Postoperative day 14-20 (wound fluid, n = 4), eP < 0.05. Plasma and wound fluid protein levels are expressed as median and 75% quartile range (Statistical significance is expressed as eP < 0.05, fP < 0.01); B: Colorectal surgery malignant patients. Preoperative vs Postoperative plasma: Preoperative vs Postoperative day 1 (n = 35), dP < 0.01; Preoperative vs Postoperative day 3 (n = 28), dP < 0.01; Preoperative vs Postoperative day 7-13(n =17), dP < 0.01; Preoperative vs Postoperative day 14-20 (n = 7), cP < 0.05. Plasma vs wound fluid: Postoperative day 1 (plasma, n = 35) vs Postoperative day 1 (wound fluid, n = 33), dP < 0.01; Postoperative day 3 (plasma, n = 28) vs Postoperative day 3 (wound fluid, n = 29), dP < 0.01; Postoperative day 7-13 (plasma, n = 17) vs Postoperative day 7-13 (wound fluid, n = 20), dP < 0.01; Postoperative day 14-20 (plasma, n = 7) vs Postoperative day 14-20 (wound fluid, n = 8), dP < 0.01. Plasma and wound fluid protein levels are expressed as median and 75% quartile range. (Statistical significance is expressed as cP < 0.05, dP < 0.01 and eP < 0.05). Preop: Preoperative; POD: Postoperative day; PLS: Plasma; WFL: Wound fluid; VEGF: Vascular endothelial growth factor.
Figure 3
Figure 3 Enzyme-Linked Immuno-Sorbent Assays determined preoperative and postoperative matrix metalloproteinase-2 levels of plasma and wound fluid levels in colorectal surgery benign patients and malignant patients. A: Colorectal surgery benign patients. Preoperative vs Postoperative plasma: Preoperative vs Postoperative day 1 (n = 26), gP < 0.05; Preoperative vs Postoperative day 3 (n = 23), hP < 0.01; Preoperative vs Postoperative day 7-13 (n = 16), gP < 0.05; Preoperative vs Postoperative day 14 -20 (n = 6), gP < 0.05. Plasma vs wound fluid: Postoperative day 1 (plasma, n = 26) vs Postoperative day 1 (wound fluid, n = 30), hP < 0.01; Postoperative day 3 (plasma, n = 23) vs Postoperative day 3 (wound fluid, n = 28), hP < 0.01; Postoperative day 7-13 (plasma, n = 16) vs Postoperative day 7-13 (wound fluid, n = 14), hP < 0.01; Postoperative day 14-20 (plasma, n = 6) vs Postoperative day 14-20 (wound fluid, n = 4), gP < 0.05; Plasma and wound fluid protein levels are expressed as median and 75% quartile range (Statistical significance is expressed as gP < 0.05, hP < 0.01); B: Colorectal surgery malignant patients. Preoperative vs Postoperative plasma: Preoperative vs Postoperative day 1 (n = 35), dP < 0.01; Preoperative vs Postoperative day 3 (n = 28), dP<0.01; Preoperative vs. Postoperative day 7-13 (n = 17), dP < 0.01; Preoperative vs Postoperative day 14-20 (n = 7), cP < 0.05. Plasma vs wound fluid: Postoperative day 1 (plasma, n = 35) vs Postoperative day 1 (wound fluid, n = 33), dP < 0.01; Postoperative day 3 (plasma, n = 28) vs Postoperative day 3 (wound fluid, n = 29), dP < 0.01; Postoperative day 7-13 (plasma, n = 17) vs Postoperative day 7-13 (wound fluid, n =20), dP < 0.01; Postoperative day 14-20 (plasma, n = 7) vs Postoperative day 14-20 (wound fluid, n = 8), dP < 0.01. Plasma and wound fluid protein levels are expressed as median and 75% quartile range. Statistical significance is expressed as cP < 0.05, dP < 0.01. Preop: Preoperative; POD: Postoperative day; PLS: Plasma; WFL: Wound fluid; MMP-2: Matrix metalloproteinase-2.
Figure 4
Figure 4 Enzyme-Linked Immuno-Sorbent Assays determined preoperative and postoperative placental growth factor levels of plasma and wound fluid levels in colorectal surgery benign patients and malignant patients. A: Colorectal surgery benign patients. Preoperative vs Postoperative plasma: Preoperative vs Postoperative day 1 (n = 26), fP < 0.01; Preoperative vs Postoperative day 3 (n = 23), fP < 0.01; Preoperative vs Postoperative day 7-13 (n = 16), eP < 0.05; Preoperative vs Postoperative day 14-20 (n = 6), ns. Plasma vs wound fluid: Postoperative day 1 (plasma, n = 26) vs Postoperative day 1 (wound fluid, n = 30), fP <0.01; Postoperative day 3 (plasma, n = 23) vs Postoperative day 3 (wound fluid, n = 28), fP <0.01; Postoperative day 7-13 (plasma, n = 16) vs Postoperative day 7-13 (wound fluid, n = 14), fP < 0.01; POD14-20 (plasma, n = 6) vs POD14-20 (wound fluid, n = 4), eP < 0.05. Plasma and wound fluid protein levels are expressed as median and 75% quartile range (Statistical significance is expressed as eP < 0.05, fP < 0.0.1); B: Colorectal surgery malignant patients. Preoperative vs Postoperative plasma: Preoperative vs Postoperative day 1 (n = 35), dP <0.01; Preoperative vs Postoperative day 3 (n = 28), dP < 0.01; Preoperative vs Postoperative day 7-13 (n = 17), dP < 0.01; Preoperative vs Postoperative day 14-20 (n = 7), cP < 0.05. Plasma vs wound fluid: Postoperative day 1 (plasma, n = 35) vs Postoperative day 1 (wound fluid, n = 33), dP < 0.01; Postoperative day 3 (plasma, n = 28) vs Postoperative day 3 (wound fluid, n = 29), dP < 0.01; Postoperative day 7-13 (plasma, n = 17) vs Postoperative day 7-13 (wound fluid, n = 20), dP < 0.01; Postoperative day 14-20 (plasma, n = 7) vs Postoperative day 14-20 (wound fluid, n = 8), dP < 0.01. Plasma and wound fluid protein levels are expressed as median and 75% quartile range. Statistical significance is expressed as cP < 0.05, dP < 0.01). Preop: Preoperative; POD: Postoperative day; PLS: Plasma; WFL: Wound fluid; PLGF: Placental growth factor.
Figure 5
Figure 5 Enzyme-Linked Immuno-Sorbent Assays determined preoperative and postoperative matrix metalloproteinase-3 levels of plasma and wound fluid levels in colorectal surgery benign patients and malignant patients. A: Colorectal surgery benign patients. Preoperative vs Postoperative plasma: Preoperative vs Postoperative day 1 (n = 26), hP < 0.01; Preoperative vs Postoperative day 3 (n = 23), hP < 0.01; Preoperative vs Postoperative day 7-13 (n = 16), hP < 0.01; Preoperative vs Postoperative day 14 -20 (n = 6), gP < 0.05; Plasma vs wound fluid: Postoperative day 1 (plasma, n = 26) vs Postoperative day 1 (wound fluid, n = 30), gP < 0.05; Postoperative day 3 (plasma, n = 23) vs Postoperative day 3 (wound fluid, n = 28), hP < 0.01; Postoperative day 7-13 (plasma, n = 16) vs Postoperative day 7-13 (wound fluid, n = 14), hP < 0.01; Postoperative day 14-20 (plasma, n = 6) vs Postoperative day 14-20 (wound fluid, n = 4), gP < 0.05. Plasma and wound fluid protein levels are expressed as median and 75% quartile range. (Statistical significance is expressed as gP < 0.05, hP < 0.01); B: Colorectal surgery malignant patients. Preoperative vs Postoperative plasma: Preoperative vs Postoperative plasma: Preoperative vs Postoperative day 1 (n = 35), jP < 0.01; Preoperative vs Postoperative day 3 (n = 28), jP < 0.01; Preoperative vs Postoperative day 7-13 (n = 17), jP < 0.01; Preoperative vs Postoperative day 14-20 (n = 7), iP < 0.05. Plasma vs wound fluid: Postoperative day 1 (plasma, n = 35) vs Postoperative day 1 (wound fluid, n = 33), jP < 0.01; Postoperative day 3 (plasma, n = 28) vs Postoperative day 3 (wound fluid, n = 29), jP < 0.01; POD7-13 (plasma, n = 17) vs POD7-13 (wound fluid, n = 20), jP < 0.01; Postoperative day 14-20 (plasma, n = 7) vs Postoperative day 14-20 (wound fluid, n = 8), iP < 0.05. Plasma and wound fluid protein levels are expressed as median and 75% quartile range. Statistical significance is expressed as iP < 0.05, jP < 0.01. Preop: Preoperative; POD: Postoperative day; PLS: Plasma; WFL: Wound fluid; MMP3: Matrix metalloproteinase-3.
Figure 6
Figure 6 Enzyme-Linked Immuno-Sorbent Assays determined preoperative and postoperative osteopontin levels of plasma and wound fluid levels in colorectal surgery benign patients and malignant patients. A: Colorectal surgery benign patients. Preoperative vs Postoperative plasma: Preoperative vs Postoperative day 1 (n = 26), hP < 0.01; Preoperative vs Postoperative day 3 (n = 23), hP < 0.01; Preoperative vs Postoperative day 7-13 (n = 16), hP < 0.01; Preoperative vs Postoperative day 14-20 (n = 6), gP < 0.05. Plasma vs wound fluid: Postoperative day 1 (plasma, n = 26) vs Postoperative day 1 (wound fluid, n = 30), hP < 0.01; Postoperative day 3 (plasma, n = 23) vs Postoperative day 3 (wound fluid, n = 28), hP < 0.01; Postoperative day 7-13 (plasma, n = 16) vs Postoperative day 7-13 (wound fluid, n = 14), hP < 0.01; Postoperative day 14-20 (plasma, n = 6) vs Postoperative day 14-20 (wound fluid, n = 4), gP < 0.05. Plasma and wound fluid protein levels are expressed as median and 75% quartile range (Statistical significance is expressed as hP < 0.05, gP < 0.01); B: Colorectal surgery malignant patients. Preoperative vs Postoperative plasma: Preoperative vs Postoperative day 1 (n = 35), dP < 0.01; Preoperative vs Postoperative day 3 (n = 28), dP < 0.01; Preoperative vs Postoperative day 7-13 (n = 17), dP < 0.01 Preoperative vs Postoperative day 14-20 (n = 7), cP < 0.05. Plasma vs wound fluid: Postoperative day 1 (plasma, n = 35) vs Postoperative day 1 (wound fluid, n = 33), dP < 0.01; Postoperative day 3 (plasma, n = 28) vs Postoperative day 3 (wound fluid, n = 29), dP < 0.01; Postoperative day 7-13 (plasma, n = 17) vs Postoperative day 7-13 (wound fluid, n = 20), dP < 0.01; Postoperative day 14-20 (plasma, n = 7) vs Postoperative day 14-20 (wound fluid, n = 8), dP < 0.01. Plasma and wound fluid protein levels are expressed as median and 75% quartile range. Statistical significance is expressed as cP < 0.05, dP < 0.01. Preop: Preoperative; POD: Postoperative day; PLS: Plasma; WFL: Wound fluid; OPN: Osteopontin.
Figure 7
Figure 7 Enzyme-Linked Immuno-Sorbent Assays determined preoperative and postoperative monocyte chemotactic protein-1 levels of plasma and wound fluid levels in colorectal surgery benign patients and malignant patients. A: Colorectal surgery benign patients. Preoperative vs Postoperative plasma: Preoperative vs Postoperative day 1 (n = 26), hP < 0.01; Preoperative vs Postoperative day 3 (n = 23), gP < 0.05; Preoperative vs Postoperative day 7-13 (n = 16), gP < 0.05; Preoperative vs Postoperative day 14-20 (n = 6), ns. Plasma vs wound fluid: Postoperative day 1 (plasma, n = 26) vs Postoperative day 1 (wound fluid, n = 30), hP < 0.01; Postoperative day 3 (plasma, n = 23) vs Postoperative day 3 (wound fluid, n = 28), hP < 0.01; Postoperative day 7-13 (plasma, n = 16) vs Postoperative day 7-13 (wound fluid, n = 14), hP < 0.01; Postoperative day 14-20 (plasma, n = 6) vs Postoperative day 14-20 (wound fluid, n = 4), gP < 0.05. Plasma and wound fluid protein levels are expressed as median and 75% quartile range (Statistical significance is expressed as gP < 0.05, hP < 0.01); B: Colorectal surgery malignant patients. Preoperative vs Postoperative plasma: Preoperative vs Postoperative day 1 (n = 35), hP < 0.01; Preoperative vs Postoperative day 3 (n = 28), hP < 0.01; Preoperative vs Postoperative day 7-13 (n = 17), gP < 0.05; Preoperative vs Postoperative day 14-20 (n = 7), gP < 0.05. Plasma vs wound fluid: Postoperative day 1 (plasma, n = 35) vs Postoperative day 1 (wound fluid, n = 33, hP < 0.01; Postoperative day 3 (plasma, n = 28) vs Postoperative day 3 (wound fluid, n = 29), hP < 0.01; Postoperative day 7-13 (plasma, n = 17) vs POD7-13 (wound fluid, n = 20), hP < 0.01; Postoperative day 14-20 (plasma, n = 7) vs Postoperative day 14-20 (wound fluid, n = 8), hP < 0.01. Plasma and wound fluid protein levels are expressed as median and 75% quartile range. Statistical significance is expressed as gP < 0.05, hP < 0.01. Preop: Preoperative; POD: Postoperative day; PLS: Plasma; WFL: Wound fluid; MCP-1: Monocyte chemotactic protein-1.
Figure 8
Figure 8 Enzyme-Linked Immuno-Sorbent Assays determined preoperative and postoperative chitinase 3 like protein-1 levels of plasma and wound fluid levels in colorectal surgery benign patients and malignant patients. A: Colorectal surgery benign patients. Preoperative vs Postoperative plasma: Preoperative vs Postoperative day 1 (n = 26), gP< 0.05; Preoperative vs Postoperative day 3 (n = 23), hP < 0.01; Preoperative vs Postoperative day 7-13 (n = 16), gP < 0.05; Preoperative vs Postoperative day 14-20 (n = 6), gP < 0.05. Plasma vs wound fluid: Postoperative day 1 (plasma, n = 26) vs Postoperative day 1 (wound fluid, n = 30), gP < 0.05; Postoperative day 3 (plasma, n = 23) vs Postoperative day 3 (wound fluid, n = 28), hP < 0.01; Postoperative day 7-13 (plasma, n = 16) vs Postoperative day 7-13 (wound fluid, n = 14), hP < 0.01; Postoperative day 14-20 (plasma, n = 6) vs POD14-20 (wound fluid, n = 4), gP < 0.05. Plasma and wound fluid protein levels are expressed as median and 75% quartile range (Statistical significance is expressed as gP < 0.05, hP < 0.01); B: Colorectal surgery malignant patients. Preoperative vs Postoperative plasma: Preoperative vs Postoperative day 1 (n = 35), hP < 0.01; Preoperative vs Postoperative day 3 (n = 28), hP < 0.01; Preoperative vs Postoperative day 7-13 (n = 17), gP < 0.05; Preoperative vs Postoperative day 14-20 (n = 7), gP < 0.05. Plasma vs wound fluid: Postoperative day 1 (plasma, n = 35) vs Postoperative day 1 (wound fluid, n = 33), gP < 0.05; Postoperative day 3 (plasma, n = 28) vs Postoperative day 3 (wound fluid, n = 29), hP < 0.01; Postoperative day 7-13 (plasma, n = 17) vs Postoperative day 7-13 (wound fluid, n = 20), hP < 0.01; Postoperative day 14-20 (plasma, n = 7) vs Postoperative day 14-20 (wound fluid, n = 8), gP < 0.05. Plasma and wound fluid protein levels are expressed as median and 75% quartile range. Statistical significance is expressed as gP < 0.05, hP < 0.0. Preop: Preoperative; POD: Postoperative day; PLS: Plasma; WFL: Wound fluid; CHI3L1: Chitinase 3 like protein-1.